Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cantor Fitzgerald
Healthtrust
Baxter
Chubb
Colorcon
Chinese Patent Office
US Army
Teva

Generated: May 20, 2018

DrugPatentWatch Database Preview

CLISTIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Clistin patents expire, and what generic alternatives are available?

Clistin is a drug marketed by Mcneil and Ortho Mcneil Pharm and is included in two NDAs.

The generic ingredient in CLISTIN is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
Summary for CLISTIN
Drug patent expirations by year for CLISTIN
Synonyms for CLISTIN
(.+/-.)-Carbinoxamine
(+-)-Carbinoxamine
{2-[(4-Chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine
{2-[(4-Chlorophenyl)-2-pyridylmethoxy]ethyl}dimethylamine
{2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]ethyl}dimethylamine
{2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]ethyl}dimethylamine maleate
2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N,N-dimethylethanamine
2-(p-Chloro-.alpha.-(2-(dimethylamino)ethoxy)benzyl)pyridine
2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine
2-[(4-chlorophenyl)-(2-pyridinyl)methoxy]-N,N-dimethylethanamine
2-[(4-chlorophenyl)-(2-pyridyl)methoxy]-N,N-dimethyl-ethanamine
2-[(4-chlorophenyl)-(2-pyridyl)methoxy]ethyl-dimethyl-amine;fumaric acid
2-[(4-chlorophenyl)-pyridin-2-yl-methoxy]-N,N-dimethyl-ethanamine
2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine
2-[(4-Chlorophenyl)(2-pyridinyl)methoxy]-N,N-dimethylethanamine #
2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine
2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine maleate
2-{[(4-chlorophenyl)(pyridin-2-yl)methyl]oxy}-N,N-dimethylethanamine
3505-38-2 (MALEATE)
486-16-8
486C168
5-21-03-00492 (Beilstein Handbook Reference)
5560-77-0
59811-38-0
6631AB
A827570
AB00053430
AB00053430_12
AC-5507
AC1L1DYK
AK116455
AKOS003334261
AKOS016843886
ALBB-023749
Allergefon
AN-10926
API0007225
AX8119987
BDBM81464
BPBio1_000729
BRD-A29426959-050-05-8
BRN 0250475
BSPBio_000661
BSPBio_001933
C06871
C16H19ClN2O
Carbinoxamin
Carbinoxamina
Carbinoxamina [INN-Spanish]
carbinoxamine
Carbinoxamine (INN)
Carbinoxamine [INN:BAN]
Carbinoxamine base
Carbinoxamine diphenyldisulfonate
Carbinoxamine maleate (Salt/Mix)
carbinoxamine tannate
Carbinoxaminum
Carbinoxaminum [INN-Latin]
CAS_486-16-8
CHEBI:3398
CHEMBL864
Clistin (Salt/Mix)
Clistin (TN)
Clistine
D00FGV
D07617
DB00748
DivK1c_000819
DTXSID4022737
EINECS 207-628-6
Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-N,N-dimethyl-
Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-N,N-dimethyl- (9CI)
Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-N,N-dimethyl-(9CI)
Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-
Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-, (-)-
Ethanamine,2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-
FT-0652011
GTPL7139
HE058679
HE345109
HE358185
I14-3528
IDI1_000819
KB-219943
KBio1_000819
KBio2_000520
KBio2_003088
KBio2_005656
KBio3_001153
KBioGR_000728
KBioSS_000520
L000924
LS-131075
McN-R 73Z
McN-R-73-Z
MFCD00050923
MolPort-006-111-418
N,N-Dimethyl-2-(p-chloro-alpha-(2-pyridyl)benzyloxy)ethylamine
NCGC00166141-01
NCGC00166141-02
NCGC00166141-03
NCGC00166141-04
NINDS_000819
NSC_2564
OJFSXZCBGQGRNV-UHFFFAOYSA-N
Oprea1_764868
Palgic
Palgic (TN)
Paracarbinoxamine
Paracarinoxamine
Prestwick0_000801
Prestwick1_000801
Prestwick2_000801
Prestwick3_000801
Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)-
Pyridine, 2-[p-chloro-.alpha.-[2-(dimethylamino)ethoxy]benzyl]-
R1807
Rondec (Salt/Mix)
Rotoxamine
SBB067454
SBI-0051304.P003
SCHEMBL5070
SPBio_000993
SPBio_002582
Spectrum_000100
Spectrum2_001127
Spectrum3_000327
Spectrum4_000264
Spectrum5_000700
ST45026379
Twiston
UNII-VED9E376NC
Ziriton (Salt/Mix)

US Patents and Regulatory Information for CLISTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil CLISTIN carbinoxamine maleate ELIXIR;ORAL 008955-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil Pharm CLISTIN carbinoxamine maleate TABLET;ORAL 008915-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Chubb
Covington
Baxter
Chinese Patent Office
Citi
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.